Overview of the latest treatments for castration-resistant prostate cancer

被引：0
|
作者：
Mohamed Bishr
Fred Saad
机构：
[1] Centre de Recherche,Urology Division
[2] Centre Hospitalier de l'Université de Montréal,undefined
[3] Centre Hospitalier de l'Université de Montréal,undefined
来源：
Nature Reviews Urology | 2013年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this Review, Saad and Bishr present an overview of the different management approaches for patients with CRPC, paying particular attention to recently approved agents and therapies that have shown promising results in phase III trials.
引用
收藏
页码：522 / 528
页数：6
相关论文
共 50 条
  • [11] Strategies in castration-resistant prostate cancer
    Bessede, Th
    PROGRES EN UROLOGIE, 2011, 21 : S68 - S71
  • [12] Abiraterone and castration-resistant prostate cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2013, 14 (02): : E48 - E48
  • [13] Diethylstilbestrol in castration-resistant prostate cancer
    Wilkins, Anna
    Shahidi, Mehdi
    Parker, Chris
    Gunapala, Ranga
    Thomas, Karen
    Huddart, Robert
    Horwich, Alan
    Dearnaley, David
    BJU INTERNATIONAL, 2012, 110 (11B) : E727 - E735
  • [14] The biology of castration-resistant prostate cancer
    Lian, Fei
    Sharma, Nitya V.
    Moran, Josue D.
    Moreno, Carlos S.
    CURRENT PROBLEMS IN CANCER, 2015, 39 (01) : 17 - 28
  • [15] Castration-resistant prostate cancer (CRPC)
    Loidl, W.
    Luger, F.
    Roosen, A.
    UROLOGE, 2014, 53 (03): : 391 - 399
  • [16] Steroidogenesis in castration-resistant prostate cancer
    Shiota, Masaki
    Endo, Satoshi
    Blas, Leandro
    Fujimoto, Naohiro
    Eto, Masatoshi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 240 - 251
  • [17] Cabazitaxel for castration-resistant prostate cancer
    Shigeta, Keisuke
    Miura, Yuji
    Naito, Yoichi
    Takano, Toshimi
    LANCET, 2011, 377 (9760): : 121 - 121
  • [18] Enzalutamide in castration-resistant prostate cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (08): : E312 - E312
  • [19] Denosumab in castration-resistant prostate cancer
    Kyrgidis, Athanassios
    Tzellos, Thrasivoulos-George
    LANCET, 2012, 379 (9828): : E50 - E50
  • [20] Corticotherapy in castration-resistant prostate cancer
    Lebdai, S.
    Branchereau, J.
    Robert, G.
    De La Tallie, A.
    Bouchaert, P.
    PROGRES EN UROLOGIE, 2013, 23 : S23 - S33
12345